Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18486629 | 0.87 | MEN1 (0.61) | MEN1KMT2APOLBNPSR1KCNH2 | |
| SCHEMBL4458096 | 0.87 | MEN1 (0.50) | MEN1KMT2APOLBNPSR1KCNH2 | |
| SCHEMBL9177686 | 0.87 | MEN1 (0.50) | MEN1KMT2APOLBNPSR1KCNH2 | |
| SCHEMBL4462717 | 0.85 | MEN1 (0.50) | MEN1KMT2APOLBNPSR1ALDH1A1 | |
| SCHEMBL4452195 | 0.84 | MEN1 (0.48) | MEN1KMT2APOLBNPSR1KCNH2 | |
| SCHEMBL4451733 | 0.83 | MEN1 (0.50) | MEN1KMT2APOLBNPSR1KCNH2 | |
| SCHEMBL4451785 | 0.82 | CYP3A4 (0.44) | MEN1KMT2A | |
| SCHEMBL4454668 | 0.82 | L3MBTL1 (0.37) | MEN1KMT2APOLBNPSR1CA12 | |
| SCHEMBL8374437 | 0.81 | LIPG (0.46) | MEN1KMT2A | |
| SCHEMBL12229785 | 0.81 | ALDH1A1 (0.58) | MEN1KMT2APOLBNPSR1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109293805-B | Olefin polymerization solid catalytic component, component preparation method and catalyst system thereof | 中国石油天然气股份有限公司 | 2021-03-09 | — | — | CN | claimed |
| CN-109293805-B | Olefin polymerization solid catalytic component, component preparation method and catalyst system thereof | 中国石油天然气股份有限公司 | 2021-03-09 | — | — | CN | disclosed |
| US-10550241-B2 | Polytrimethylene terephthalate composition, polyester fiber, and methods for producing the same | TEIJIN FRONTIER CO., LTD. (JP) | 2020-02-04 | — | — | US | disclosed |
| EP-3249012-B1 | POLYTRIMETHYLENE TEREPHTHALATE COMPOSITION, POLYESTER FIBERS, AND METHOD FOR PRODUCING SAME | TEIJIN FRONTIER CO LTD (JP) | 2019-08-21 | — | — | EP | disclosed |
| US-20180265667-A1 | POLYTRIMETHYLENE TEREPHTHALATE COMPOSITION, POLYESTER FIBER, AND METHODS FOR PRODUCING THE SAME | TEIJIN LIMITED (JP) | 2018-09-20 | — | — | US | disclosed |
| US-10017629-B2 | Polyethylene-2,6-naphthalate composition with excellent blow moldability, and molded product thereof | TEIJIN LIMITED (JP) | 2018-07-10 | — | — | US | disclosed |
| EP-3109271-B1 | POLYETHYLENE-2,6-NAPHTHALATE COMPOSITION WITH EXCELLENT BLOW MOLDABILITY, AND MOLDED PRODUCT THEREOF | TEIJIN LTD (JP) | 2018-03-28 | — | — | EP | disclosed |
| EP-3249012-A1 | POLYTRIMETHYLENE TEREPHTHALATE COMPOSITION, POLYESTER FIBERS, AND METHOD FOR PRODUCING SAME | Teijin Limited (JP) | 2017-11-29 | — | — | EP | disclosed |
| EP-3109271-A1 | POLYETHYLENE-2,6-NAPHTHALATE COMPOSITION WITH EXCELLENT BLOW MOLDABILITY, AND MOLDED PRODUCT THEREOF | Teijin Limited (JP) | 2016-12-28 | — | — | EP | disclosed |
| US-20160347934-A1 | POLYETHYLENE-2,6-NAPHTHALATE COMPOSITION WITH EXCELLENT BLOW MOLDABILITY, AND MOLDED PRODUCT THEREOF | TEIJIN LIMITED (JP) | 2016-12-01 | — | — | US | disclosed |
| EP-2256124-A1 | Phospho-indoles as HIV inhibitors | IDENIX Pharmaceuticals, Inc. (US) | 2010-12-01 | — | — | EP | disclosed |
| EP-1961757-B1 | Phosphoindoles as HIV inhibitors | IDENIX PHARMACEUTICALS INC (US) | 2010-09-01 | — | — | EP | disclosed |
| US-7612148-B2 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2009-11-03 | — | — | US | disclosed |
| US-20090163444-A1 | PHOSPHO-INDOLES AS HIV INHIBITORS | IDENIX PHARMACEUTICALS LLC | 2009-06-25 | — | — | US | disclosed |
| US-20090163444-A1 | PHOSPHO-INDOLES AS HIV INHIBITORS | IDENIX PHARMACEUTICALS LLC | 2009-06-25 | — | — | US | disclosed |
| US-7534809-B2 | Phospho-indoles as HIV inhibitors | IDENIX PHARMACEUTICALS, INC. (US) | 2009-05-19 | — | — | US | disclosed |
| US-7534809-B2 | Phospho-indoles as HIV inhibitors | IDENIX PHARMACEUTICALS, INC. (US) | 2009-05-19 | — | — | US | disclosed |
| EP-1799696-B1 | PHOSPHOINDOLES AS HIV INHIBITORS | IDENIX PHARMACEUTICALS INC (US) | 2008-11-12 | — | — | EP | disclosed |
| EP-1961757-A1 | Phosphoindoles as HIV inhibitors | IDENIX Pharmaceuticals, Inc. (US) | 2008-08-27 | — | — | EP | disclosed |
| US-20080146733-A1 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163444-A1 | PHOSPHO-INDOLES AS HIV INHIBITORS | IDO1, PPP5C, INMT | MEN1 3483/4885KMT2A 1767/4885POLB 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.